Exploring the current use and future of alternatives to traditional informed consent in acute stroke trials

The University of Cincinnati’s Yasmin Aziz, MD, and Joseph Broderick, MD, coauthored an editorial published Nov. 7 in the journal Neurology analyzing the current use and potential future of alternatives to traditional informed consent in acute stroke trials.

New strategy for mRNA nanocarriers using triphenyl phosphonium

Among the vastly different ways of tackling a disease, controlling the genetic expression of cells is undoubtedly one of the most powerful. Over the past

July 23, 2024

MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million – Biotech Investments

MorphoSys AG / Key word(s): Capital Increase Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7

December 15, 2023

Riding on positive data, argenx raises $1.1B while Alzheimer’s biotech Acumen lands $130M

An immunology player and an Alzheimer’s biotech each have a big boost in cash — a massive $1.1 billion for argenx and $130 million for

July 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.